Literature DB >> 1457267

The influence of posture on the pharmacokinetics of orally administered nifedipine.

A G Renwick1, C H Ahsan, V F Challenor, R Daniels, B S Macklin, D G Waller, C F George.   

Abstract

1. Nifedipine (20 mg as capsules) and soluble paracetamol (1 g) were co-administered to eight healthy young volunteers on three separate occasions, following which in random order they stood, lay on their left side or lay on their right side for 4 h. 2. The time to maximum plasma concentration of paracetamol was significantly lower when standing or lying on the right side compared with recumbent left, indicating more rapid gastric emptying. 3. The times to maximum plasma concentrations of nifedipine and its metabolite produced at first pass were reduced when standing or lying on the right side. These postures were associated with significantly higher peak plasma concentrations and AUC values of nifedipine but not of its nitropyridine metabolite. 4. The increase in heart rate following nifedipine administration was significantly greater when lying on the right side compared with the left. 5. The data are consistent with transient saturation of first pass metabolism of nifedipine with postures which favour rapid gastric emptying. The results demonstrate the importance of defining the precise posture in studies in which pharmacokinetic and pharmacodynamic measurements are made on drugs which are absorbed rapidly and are subject to presystemic elimination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457267      PMCID: PMC1381416          DOI: 10.1111/j.1365-2125.1992.tb05639.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Effect of body position on gastric emptying in the neonate.

Authors:  Y H Victor
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

2.  The effect of exercise on the splanchnic blood flow and splanchnic blood volume in normal man.

Authors:  S E BRADLEY; A W CHILDS; B COMBES; A COURNAND; O L WADE; H O WHEELER
Journal:  Clin Sci       Date:  1956-08       Impact factor: 6.124

3.  Ethnic differences in the pharmacokinetics of oral nifedipine.

Authors:  C H Ahsan; A G Renwick; B Macklin; V F Challenor; D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

4.  The effect of the upright posture upon hepatic blood flow in normotensive and hypertensive subjects.

Authors:  J W CULBERTSON; R W WILKINS; F J INGELFINGER; S E BRADLEY
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

5.  Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects.

Authors:  J H Schellens; P A Soons; D D Breimer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

Review 6.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

7.  The first pass metabolism of nifedipine in man.

Authors:  D G Waller; A G Renwick; B S Gruchy; C F George
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

8.  Posture and theophylline kinetics.

Authors:  J B Warren; F Cuss; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

9.  Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites.

Authors:  R H Rumble; M S Roberts; M J Denton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

10.  Does lying on the right side increase the rate of gastric emptying?

Authors:  R Burn-Murdoch; M A Fisher; J N Hunt
Journal:  J Physiol       Date:  1980-05       Impact factor: 5.182

View more
  9 in total

Review 1.  Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations.

Authors:  B Oosterhuis; J H Jonkman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

2.  Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.

Authors:  A Sowunmi; T J Rashid; O O Akinyinka; A G Renwick
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

3.  Computational modeling of drug dissolution in the human stomach: Effects of posture and gastroparesis on drug bioavailability.

Authors:  J H Lee; S Kuhar; J-H Seo; P J Pasricha; R Mittal
Journal:  Phys Fluids (1994)       Date:  2022-08-09       Impact factor: 4.980

Review 4.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

5.  Factors affecting the absolute bioavailability of nifedipine.

Authors:  T J Rashid; U Martin; H Clarke; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

Review 6.  Influence of posture on pharmacokinetics.

Authors:  Christian Queckenberg; Uwe Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2008-10-21       Impact factor: 2.953

7.  Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.

Authors:  J Rashid; C McKinstry; A G Renwick; M Dirnhuber; D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 8.  Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature.

Authors:  Cinzia Dello Russo; Tiziano Bandiera; Monica Monici; Leonardo Surdo; Vincent Lai Ming Yip; Virginia Wotring; Lucia Morbidelli
Journal:  Br J Pharmacol       Date:  2022-03-15       Impact factor: 9.473

9.  Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.

Authors:  Zhen-Yu Cheng; Xin Tian; Jie Gao; Hong-Meng Li; Lin-Jing Jia; Hai-Ling Qiao
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.